India In GE Plan For $50 Million Funds For India-Focused Diagnostics
This article was originally published in PharmAsia News
Executive SummaryIndia is about to get an additional $50 million from GE Healthcare, a U.S.-based maker or medical devices planning to develop low-cost diagnostic imagers
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.